Carson Holliday
Twist Bioscience (United States)(US)University of Washington Bothell(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Diabetes Management and Research, Pancreatic function and diabetes, Hyperglycemia and glycemic control in critically ill and hospitalized patients, HER2/EGFR in Cancer Research
Most-Cited Works
- → Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism(2023)6 cited
- → A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway(2025)2 cited
- → A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants(2024)1 cited
- → A multi-faceted discovery strategy identifies functional Dickkopf-1 antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway 2061(2025)
- → Abstract A111: Preclinical evaluation of HC74, a novel topoisomerase I inhibitor payload for antibody–drug conjugates that overcomes multi-drug resistance(2025)
- → Abstract 2649: Discovery of a potent, selective, and tumor-suppressing antibody antagonist of DKK1(2023)
- → Abstract 1531: Human anti-CD40 agonistic antibodies with enhanced FcgR engagement activate immune cell and promote anti-tumor efficacy(2023)
- → Functional DKK1 antibodies demonstrate antagonistic and tumor suppression activities(2023)